Studies related to Symptoms of Diabetic Neuropathy and Alpha-Lipoic Acid | Examine.com

Efficacy And Safety Of Antioxidant Treatment With α-lipoic Acid Over 4 Years In Diabetic Polyneuropathy: The NATHAN 1 Trial

Effect	None
Trial Design	Double blind
Trial Length	6+ Months
Number of Subjects	460
Sex	Both Genders
Age Range	45-64
Body Types	Obese, Overweight

Notes for this study:

4 years usage of 600mg ALA racemic mixture daily was unable to offer protection from diabetes, and was not significantly more effective than placebo.

Full details on all 2 studies are available to Examine members — try free for 14 days.

Already a member? Log in now to access.